UB Paderborn / Katalog / Suche / in CDI

Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer

Prostate cancer and prostatic diseases, 2013-06, Vol.16 (2), p.132-138

2013

Volltextzugriff (PDF)

Prostate Cancer Cells (LNCaP) Generated after Long-Term Interleukin 6 (IL-6) Treatment Express IL-6 and Acquire an IL-6 Partially Resistant Phenotype

Clinical cancer research, 2001-09, Vol.7 (9), p.2941-2948

2001

Volltextzugriff (PDF)

Risk-modelling of prostate carcinoma using anti-nutrient serum Anti-Food Immunoglobulines (AFIG)

European urology open science (Online), 2022-10, Vol.44, p.S203

2022

Volltextzugriff (PDF)

Immunotherapy of Metastatic Renal Cell Carcinoma with Tumor Lysate-pulsed Autologous Dendritic Cells

Clinical cancer research, 2002-11, Vol.8 (11), p.3369-3376

2002

Volltextzugriff (PDF)

Up-Regulation of Functional Chemokine Receptor CCR3 in Human Renal Cell Carcinoma

Clinical cancer research, 2005-04, Vol.11 (7), p.2459-2465

2005

Volltextzugriff (PDF)

Interleukin 1β mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells

British journal of cancer, 1998-10, Vol.78 (8), p.1004-1011

1998

Volltextzugriff (PDF)

Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide

Cancer Immunology, Immunotherapy, 2005-07, Vol.54 (7), p.663-670

2005

Volltextzugriff (PDF)

Nordihydroguaiaretic acid blocks secretory and endocytic pathways in human dendritic cells

Journal of leukocyte biology, 1998-12, Vol.64 (6), p.747-752

1998

Volltextzugriff (PDF)

EXPRESSION AND IMMUNOGENICITY OF ONCOFETAL ANTIGEN-IMMATURE LAMININ RECEPTOR IN HUMAN RENAL CELL CARCINOMA

The Journal of urology, 2001-05, Vol.165 (5), p.1705-1709

2001

Volltextzugriff (PDF)

Small G-protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosis

The Prostate, 2005-09, Vol.64 (4), p.332-340

2005

Volltextzugriff (PDF)

Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells

The Prostate, 2004-02, Vol.58 (3), p.259-268

2004

Volltextzugriff (PDF)

In vitro generation of CD83+ human blood dendritic cells for active tumor immunotherapy

Experimental hematology, 1997-03, Vol.25 (3), p.232-237

1997

Volltextzugriff (PDF)

Bee venom secretory phospholipase A2 and phosphatidylinositol-homologues cooperatively disrupt membrane integrity, abrogate signal transduction and inhibit proliferation of renal cancer cells

Cancer Immunology, Immunotherapy, 2007-05, Vol.56 (5), p.627-640

2007

Volltextzugriff (PDF)

CELLULAR AND HUMORAL IMMUNE RESPONSES IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA AFTER VACCINATION WITH ANTIGEN PULSED DENDRITIC CELLS

The Journal of urology, 1999-03, Vol.161 (3), p.777-782

1999

Volltextzugriff (PDF)

Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides

Cancer gene therapy, 2000-07, Vol.7 (7), p.997-1007

2000

Volltextzugriff (PDF)

305 Differential metabolic effects of medium-chain triglycerides and omega-3 fatty acids in benign and malignant prostate cells – evidence for a ketogenic diet as adjuvant therapy for prostate cancer

European urology supplements : official journal of the European Association of Urology, 2014-04, Vol.13 (1), p.e305-e305

2014

Volltextzugriff (PDF)

IL-4 inhibits the TNF-α induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-α to induce apoptotic and cytokine responses by RCC : implications for antitumor immune responses

Cancer Immunology, Immunotherapy, 2006-10, Vol.55 (10), p.1228-1237

2006

Volltextzugriff (PDF)

Dendritic-cell activation by secretory phospholipase A2

Blood, 2005-05, Vol.105 (9), p.3583-3587

2005

Volltextzugriff (PDF)

CD83+ blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancer

The Lancet (British edition), 1998-10, Vol.352 (9137), p.1358-1358

1998

Volltextzugriff (PDF)

The disabled dendritic cell

The FASEB journal, 2001-04, Vol.15 (6), p.1054-1061

2001

Volltextzugriff (PDF)

An Escherichia coli-based oral vaccine against urinary tract infections potently activates human dendritic cells

Urology (Ridgewood, N.J.), 2002-09, Vol.60 (3), p.521-526

2002

Volltextzugriff (PDF)

Human renal‐cell carcinoma tissue contains dendritic cells

International journal of cancer, 1996-09, Vol.68 (1), p.1-7

1996

Volltextzugriff (PDF)

Human monocyte-derived dendritic cells are deficient in prostaglandin E2 production

FEBS letters, 2002-01, Vol.511 (1), p.123-126

2002

Volltextzugriff (PDF)

Bacillus Calmette‐Guérin mycobacteria stimulate human blood dendritic cells

International journal of cancer, 1997-01, Vol.70 (1), p.128-134

1997

Volltextzugriff (PDF)

Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells

British journal of cancer, 1998-10, Vol.78 (8), p.1004-1011

1998

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer

Prostate Cancer Cells (LNCaP) Generated after Long-Term Interleukin 6 (IL-6) Treatment Express IL-6 and Acquire an IL-6 Partially Resistant Phenotype

Risk-modelling of prostate carcinoma using anti-nutrient serum Anti-Food Immunoglobulines (AFIG)

Immunotherapy of Metastatic Renal Cell Carcinoma with Tumor Lysate-pulsed Autologous Dendritic Cells

Up-Regulation of Functional Chemokine Receptor CCR3 in Human Renal Cell Carcinoma

Interleukin 1β mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells

Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide

Nordihydroguaiaretic acid blocks secretory and endocytic pathways in human dendritic cells

EXPRESSION AND IMMUNOGENICITY OF ONCOFETAL ANTIGEN-IMMATURE LAMININ RECEPTOR IN HUMAN RENAL CELL CARCINOMA

Small G-protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosis

Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells

In vitro generation of CD83+ human blood dendritic cells for active tumor immunotherapy

Bee venom secretory phospholipase A2 and phosphatidylinositol-homologues cooperatively disrupt membrane integrity, abrogate signal transduction and inhibit proliferation of renal cancer cells

CELLULAR AND HUMORAL IMMUNE RESPONSES IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA AFTER VACCINATION WITH ANTIGEN PULSED DENDRITIC CELLS

Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides

305 Differential metabolic effects of medium-chain triglycerides and omega-3 fatty acids in benign and malignant prostate cells – evidence for a ketogenic diet as adjuvant therapy for prostate cancer

IL-4 inhibits the TNF-α induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-α to induce apoptotic and cytokine responses by RCC : implications for antitumor immune responses

Dendritic-cell activation by secretory phospholipase A2

CD83+ blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancer

The disabled dendritic cell

An Escherichia coli-based oral vaccine against urinary tract infections potently activates human dendritic cells

Human renal‐cell carcinoma tissue contains dendritic cells

Human monocyte-derived dendritic cells are deficient in prostaglandin E2 production

Bacillus Calmette‐Guérin mycobacteria stimulate human blood dendritic cells

Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells

Suchergebnisse filtern